0001209191-20-014229.txt : 20200228
0001209191-20-014229.hdr.sgml : 20200228
20200228200258
ACCESSION NUMBER: 0001209191-20-014229
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200228
FILED AS OF DATE: 20200228
DATE AS OF CHANGE: 20200228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARTIN JOHN C
CENTRAL INDEX KEY: 0001190578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 20673744
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: X1
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-28
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001190578
MARTIN JOHN C
215 FIRST STREET, SUITE 415
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2020-02-28
4
A
0
3112
0.00
A
3112
D
Common Stock
2020-02-28
4
A
0
2075
0.00
A
5187
D
Stock option (right to buy)
114.47
2020-02-28
4
A
0
5528
0.00
A
2020-02-28
Common Stock
5528
5528
D
Stock option (right to buy)
114.47
2020-02-28
4
A
0
3685
0.00
A
2021-02-28
2020-02-28
Common Stock
3685
3685
D
The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning February 28, 2021.
The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021.
The option vests in three equal annual installments beginning February 28, 2021.
/s/ David Tyronne Howton, as Attorney-in-Fact for John C. Martin
2020-02-28